Skip to content
Search

Latest Stories

CPE April Committee Meeting Concludes: Know Key Matters Discussed

CPE April Committee Meeting Concludes: Know Key Matters Discussed

The Community Pharmacy England publishes the summary of its April 2024 Committee Meeting

A full CPE Committee Meeting was organised in London on April 17 and 18, 2024, to discuss crucial sectoral issues.

Key topics discussed during the two-day meeting included intolerable pressures on pharmacy owners, the ongoing Community Pharmacy Contractual Framework (CPCF) negotiations, implementation of the Pharmacy First service, and governance changes.


Committee Members reviewed the progress of CPCF negotiations with the Department of Health and Social Care (DHSC) and NHS England. These critical negotiations are being led by the Negotiating Team (NT), which includes independent pharmacy owners and representatives of CCA and non-CCA multiples.

The CPE has been advocating for an uplift to the core global sum, margin write-offs, an agreed mechanism for regular funding increases linked to activity and inflation, annual uplifts to service fees, more fundamental reform of the margin delivery framework and an economic review of the medicines supply chain.

The Committee also discussed the results of the 2024 Pharmacy Pressures Survey, which was conducted during March and April.

The survey results “paint a picture of a community pharmacy sector in deep distress, with direct knock-on impacts for patients,” said the CPE, adding that the findings will be released in due course.

CPE Chief Executive Janet Morrison said: “This was another important meeting for the Community Pharmacy England Committee, with all members very sharply focused on the desperate state of the sector.

“As business owners themselves, the distressing findings of this year’s Pressures Survey came as no surprise, and all attention in the room was centred on how to find solutions and assure the sustainability of community pharmacies for this year and beyond.”

Commenting on the ongoing CPCF negotiations, she said that the Negotiating Team is working hard to get the best deal on the table.

“We have also been working to prepare to make pharmacy’s case ahead of the Spending Review expected shortly after the upcoming General Election. This is alongside influencing work to build support for investment in pharmacy across all political parties and candidates.”

Morrison also revealed plans to roll out a Pharmacy Advice Audit in the upcoming months to assess the broader impact of the Pharmacy First service in attracting individuals to pharmacies.

“The efforts of all pharmacy teams to implement Pharmacy First have been phenomenal, and it was good to hear that the service is already having a positive impact for patients, with pharmacists also enjoying being able to offer the service,” she noted.

Nevertheless, she acknowledged the persisting challenges and affirmed their commitment to influence the DHSC and NHS England to tackle these issues and raise awareness of this strategically vital service.

LPC leaders from the South East region attended part of the meeting and shared feedback from local pharmacy owners.

Marc Donovan, a Community Pharmacy England Member and Chair of the Community Pharmacy Workforce Development Group (CPWDG), gave an update to the Committee on workforce issues and the actions the group is taking to address them.

More For You

Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less
Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

Patients who purchase two prescriptions per month could save more than £110 annually with a 12-month PPC.

Getty Images

Prepayment certificates helped patients avoid £837M in prescription fees, NHSBSA analysis reveals

The NHS Business Services Authority (NHSBSA) has published a new experimental analysis, estimating patient savings achieved from prescription prepayment certificates (PPCs), including Hormone Replacement Therapy (HRT) PPCs.

The report revealed that the number of Prescription Prepayment Certificates (PPCs) purchased has risen consistently over the past five years, with 3.3 million patients receiving NHS prescriptions under a PPC exemption in 2023/2024.

Keep ReadingShow less